Programm

Freitag, 5. April 2019

Coffee and snacks provided at the lobby

Registration at the lobby

Introduction and Opening Remarks - 7th Heidelberg Myeloma Workshop

Hartmut Goldschmidt, Heidelberg
Marc S. Raab, Heidelberg
Carsten Müller-Tidow, Heidelberg
Stefan Fröhling, Heidelberg
Michael Baumann, Heidelberg
Annette Grüters-Kieslich, Heidelberg

Session I
Diagnostics and Prognostic Factors

Moderator: Siegfried Janz, Milwaukee

Major Prognostic Factors in Patients with SMM and MM

Herve Avet-Loiseau, Toulouse

Discussion

Novel Imaging Techniques in Multiple Myeloma

Jens Hillengaß, Buffallo

Discussion

Current and Future Concepts in PET - Imaging

Martin Kortüm, Würzburg

Discussion

Biology of High-Risk Myeloma “del17p Myeloma: Biology and Prognosis”

Anjan Thakurta, Summit

Discussion

Key Note Lecture

Introducing Shaji Kumar (Marc S. Raab)
How to Define and when to Treat Smoldering Multiple Myeloma
Shaji Kumar, Rochester

Discussion

Coffee Break - Drinks, Snacks and Small Appetizers

Session II
Role of Immunotherapy in Multiple Myeloma

Moderator: Michael Schmitt, Heidelberg

Myeloma Biology: Basic Principles of Immunotherapy

Paola Neri, Calgary

Discussion

Antibodies in Myeloma: Clinical Efficacy and Management

Niels van de Donk, Amsterdam

Discussion

Innovative Immunotherapies Including Car-T Cells

Adam D. Cohen, Philadelphia

Discussion

Key Note Lecture

Introducing Brian Durie (Hartmut Goldschmidt)
MRD - Negativity for all Patients
Brian Durie, Los Angeles

Discussion

Coffee Break - Drinks, Snacks and Small Appetizers

Session III
Current Therapy of Multiple Myeloma

Moderator: Heinz Ludwig, Wien

First-line Therapy for Non-Transplant Eligible Patients

Katja Weisel, Tübingen

Discussion

Updated Results on Double Transplant in First-line

Michele Cavo, Bologna

Discussion

Treatment of High-Risk Myeloma

Nicola Giesen, Heidelberg

Discussion

The Role of Allogeneic Transplantation

Nicolaus Kröger, Hamburg-Eppendorf

Discussion

When and How to Treat Relapsed Multiple Myeloma

Christof Scheid, Köln

Discussion

Summary - Day one

Hartmut Goldschmidt, Heidelberg

Dinner

Palais Prince Carl, Kornmarkt 1, 69117 Heidelberg

Samstag, 6. April 2019

Key Note Lecture

Introducing Kenneth Anderson (Marc S. Raab)
The Future of Myeloma Therapy in the Next Decade
Kenneth C. Anderson, Boston

Discussion

DEBATE: MRD Driven Therapy - Ready for Primetime

Moderator: Michael Hundemer, Heidelberg

Molecular Techniques for Detection of MRD - Feasibility and Reliability

Stefanie Huhn, Heidelberg

Discussion

YES: MRD Negativity is a Strong Predictor of Clinical Outcomes

Ola Landgren, Bethesda

Discussion

NO: Lack of Standardization Suggests it is not yet a Standard of Care in Clinical Practice

Martin Kaiser, London

Discussion

Session IV
Biology and Genomics of Multiple Myeloma

Moderator: Aldo M. Roccaro, Brescia

Radiogenomics

Leo Rasche, Würzburg

Discussion

Genetic Heterogeneity and Genomic Evolution

Niels Weinhold, Heidelberg

Discussion

Non-Evasive Techniques for Detection

Bruno Paiva, Pamplona

Discussion

Analyzing the Single Myeloma Cell

Jens G. Lohr, Boston

Discussion

Key Note Lecture

Introducing Bart Barlogie (Niels Weinhold)
The Road to Cure in Multiple Myeloma       
Bart Barlogie, New York

Lunch - Buffet

Session V
Novel Concepts

Moderator: Christoph Driessen, St. Gallen

Development of Personalized Medicine in Multiple Myeloma

Keith Stewart, Rochester

Discussion

Emerging Drugs and Targets

Marc S. Raab, Heidelberg

Discussion

ProTACs - Targeting the Undrugables?

Nizar Bahlis, Calgary

Discussion

AL Amyloidosis – Organ Responses to Novel Therapies

Stefan Schönland, Heidelberg

Discussion

Deutsche Studiengruppe Multiples Myelom
Current and Novel Trials of DSMM

Stefan Knop, Würzburg

Discussion

German-speaking Myeloma Multicenter Group
Current and Novel Trials of GMMG

Hartmut Goldschmidt, Heidelberg

Discussion

Summary of the 7th Heidelberg Myeloma Workshop

Hartmut Goldschmidt, Heidelberg